Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...

Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

Danish drugmaker Novo Nordisk is working to bring its blockbuster drug Ozempic to India “as soon as possible", Dr Yan Cai, ...

India is among the top two countries in terms of type 2 diabetes cases and third in terms of obesity; hence, the need for ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

July kicks off the latter half of 2025, and the first six months of this year have been eventful, to say the least. Yet, the broader market is once again near all-time highs, a testament to the ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

At first, Chinese pharmaceutical companies rushed to make similar versions of blockbuster weight-loss drugs, such as Wegovy and Ozempic, that have taken the ... cyclic adenosine monophosphate, a ...